Emanuele Puca

Emanuele Puca currently serves as a board member and internal control manager at Philochem AG since January 2020. Prior to this role, Emanuele Puca was a PhD student at ETH Zürich from February 2017 to December 2019, focusing on the antibody-based delivery of proinflammatory cytokines, particularly interleukin-12, for cancer treatment. Emanuele Puca holds a Master's degree in Pharmaceutical Sciences from ETH Zürich and a Laurea Magistrale LM in Farmacia from Sapienza Università di Roma. Educational background also includes attendance at Lycée Chateaubriand de Rome from 1995 to 2010.